Anavex Life Sciences
AVXL
67 hedge funds and large institutions have $36.1M invested in Anavex Life Sciences in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 8 reducing their positions, and 5 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 8
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
10% more funds holding
Funds holding: 61 → 67 (+6)
0.72% less ownership
Funds ownership: 25.52% → 24.8% (-0.72%)
15% less capital invested
Capital invested by funds: $42.6M → $36.1M (-$6.56M)
82% less call options, than puts
Call options by funds: $344K | Put options by funds: $1.87M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$315K |
| 2 |
BlackRock
New York
|
+$239K |
| 3 |
Renaissance Technologies
New York
|
+$214K |
| 4 |
D.E. Shaw & Co
New York
|
+$188K |
| 5 |
Morgan Stanley
New York
|
+$120K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WG
Winton Group
London,
United Kingdom
|
-$291K |
| 2 |
HP
Hikari Power
Tokyo,
Japan
|
-$102K |
| 3 |
EWM
Edge Wealth Management
New York
|
-$63K |
| 4 |
VF
Virtu Financial
New York
|
-$43.3K |
| 5 |
Squarepoint
New York
|
-$40K |
AVXL Hedge Fund Activity: Q4 2019 in Review
67 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q4 2019, worth a combined $36.1M — down 15% from $42.6M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new AVXL positions and 5 closed out — a net gain of 7 holders — while 24 added to existing stakes and 8 trimmed.
The largest buyer was Park West Asset Management, adding an estimated $315K. The largest seller was Winton Group, exiting entirely with an estimated $291K sold.
- 67 institutional investors held Anavex Life Sciences (AVXL) as of Q4 2019, up from 61 in Q3 2019.
- Funds reported $36.1M of Anavex Life Sciences stock for Q4 2019, down 15% quarter-over-quarter.
- 12 funds opened new Anavex Life Sciences positions in Q4 2019 and 5 closed out, a net change of +7 holders.
- The largest Anavex Life Sciences buyer in Q4 2019 was Park West Asset Management, an estimated $315K added.
- The largest Anavex Life Sciences seller in Q4 2019 was Winton Group, an estimated $291K sold.
Based on aggregated 13F filings for Q4 2019.